COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,690 Articles (22,913 medRxiv, 8,777 bioRxiv)

Most recent first Previous |  Page 1968: Articles 19671-19680  | Next

The Impact of the November 2020 English National Lockdown on COVID-19 case counts
Hunter, P. R., Brainard, J. S., Grant, A. R.
10.1101/2021.01.03.21249169 — Posted: 2021-01-04
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Havervall, S., Jernbom Falk, A., Klingstrom, J., Ng, H., Greilert Norin, N., Gabrielsson, L., Salomonsson, A.-C., Isaksson, E., Rudberg, A.-S., Hellstrom, C., Andersson, E., Olofsson, J., Skoglund, L., Yousef, J., Pin, E., Christ, W., Olausson, M., Hedhammar, M., Tegel, H., Mangsbo, S., Phillipson, M., Manberg, A., Hober, S., Nilsson, P., Thalin, C.
10.1101/2021.01.03.21249162 — Posted: 2021-01-04
Autoimmune anti-DNA antibodies predict disease severity in COVID-19 patients
Gomes, C., Zuniga, M., Crotty, K. A., Qian, K., Hsu Lin, L., Argyropoulos, K., Li, H., Cotzia, P., Rodriguez, A.
10.1101/2021.01.04.20249054 — Posted: 2021-01-04
Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2
Trombetta, B. A., Kandigian, S. E., Kitchen, R. R., Grauwet, K., Webb, P. K., Miller, G. A., Jennings, C. G., Jain, S., Miller, S. M., Kuo, Y., Sweeney, T., Gilboa, T., Norman, M., Simmons, D. P., Ramirez, C. E., Bedard, M., Fink, C., Ko, J., Peralta, E. J. D. L., Watts, G., Gomez-Rivas, E., Davis, V., Barilla, R., Wang, J., Cunin, P., Bates, S., Morrison-Smith, C., Nicholson, B., Wong, E., El-Mufti, L., Kann, M., Bolling, A., Fortin, B., Ventresca, H., Zhou, W., Pardo, S., Kwock, M., Hazra, A., Cheng, L., Ahmad, R., Toombs, J. A., Larson, R., Pleskow, H., Luo, N. M., Samaha, C., Pandya, U. M., De Silva, P., Zhou, S., Ganhadeiro, Z., Yohannes, S., Gay, R., Slavik, J., Mukerji, S. S., Jarolim, P., Walt, D. R., Carlyle, B. C., Ritterhouse, L. L., Suliman, S.
10.1101/2021.01.02.20248998 — Posted: 2021-01-04
Nested pool testing strategy for the reliable identification of individuals infected with SARS-CoV-2
Armendariz, I., Ferrari, P. A., Fraiman, D., Martinez, J. M., Menzella, H. G., Ponce Dawson, S.
10.1101/2021.01.03.21249170 — Posted: 2021-01-04
Humoral and cell-mediated response in colostrum after exposure to severe acute respiratory syndrome coronavirus 2
Narayanaswamy, V., Pentecost, B., Alfandari, D., Chin, E., Minor, K., Kastrinakis, A., Lieberman, T., Arcaro, K. F., Leftwich, H.
10.1101/2021.01.03.20248715 — Posted: 2021-01-04
Brazilian model estimation for SARS-CoV-2 peak contagion (BMESPC): first and second wave
Asai, G., Kuroiva, A., Terra, M. L.
10.1101/2021.01.02.20248940 — Posted: 2021-01-04
Burden of predominant psychological reactions among the healthcare workers and general during COVID-19 pandemic phase: a systematic review and meta-analysis
Thakur, B., Pathak, M.
10.1101/2021.01.02.21249126 — Posted: 2021-01-04
Spatial-temporal relationship between population mobility and COVID-19 outbreaks in South Carolina: A time series forecasting analysis
Zeng, C., Zhang, J., Li, Z., Sun, X., Olatosi, B., Weissman, S., Li, X.
10.1101/2021.01.02.21249119 — Posted: 2021-01-04
COVID-19 Vaccine Acceptance Among Health Care Workers in the United States
Shekhar, R., Sheikh, A. B., Upadhyay, S., Singh, M., Kottewar, S., Mir, H., Barrett, E., Pal, S.
10.1101/2021.01.03.21249184 — Posted: 2021-01-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).